260 related articles for article (PubMed ID: 30301276)
1. Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease.
Kim OY; Lee SM; An WS
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30301276
[TBL] [Abstract][Full Text] [Related]
2. Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients.
Son YK; Lee SM; Kim SE; Kim KH; Lee SY; Bae HR; Han JY; Park Y; An WS
J Ren Nutr; 2012 Jan; 22(1):58-66. PubMed ID: 21620727
[TBL] [Abstract][Full Text] [Related]
3. Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortality.
Shearer GC; Carrero JJ; Heimbürger O; Barany P; Stenvinkel P
J Ren Nutr; 2012 Mar; 22(2):277-283. PubMed ID: 21775161
[TBL] [Abstract][Full Text] [Related]
4. The C18:3n6/C22:4n6 ratio is a good lipid marker of chronic kidney disease (CKD) progression.
Szczuko M; Kaczkan M; Małgorzewicz S; Rutkowski P; Dębska-Ślizień A; Stachowska E
Lipids Health Dis; 2020 Apr; 19(1):77. PubMed ID: 32303226
[TBL] [Abstract][Full Text] [Related]
5. Plasma fatty acids and kidney function decline in post-myocardial infarction patients of the Alpha Omega Cohort.
van Westing AC; Eckl MR; Küpers LK; Pertiwi K; Hoogeveen EK; Geleijnse JM
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1467-1476. PubMed ID: 33744039
[TBL] [Abstract][Full Text] [Related]
6. Blood Fatty Acid Profiles: New Biomarkers for Cardiometabolic Disease Risk.
Jackson KH; Harris WS
Curr Atheroscler Rep; 2018 Mar; 20(5):22. PubMed ID: 29556735
[TBL] [Abstract][Full Text] [Related]
7. Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial.
Markey O; Vasilopoulou D; Kliem KE; Koulman A; Fagan CC; Summerhill K; Wang LY; Grandison AS; Humphries DJ; Todd S; Jackson KG; Givens DI; Lovegrove JA
Nutr J; 2017 May; 16(1):33. PubMed ID: 28535777
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of ω -3 PUFAs in chronic kidney disease.
Lee SM; An WS
Biomed Res Int; 2013; 2013():712949. PubMed ID: 23653897
[TBL] [Abstract][Full Text] [Related]
9. Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?
Block RC; Harris WS; Reid KJ; Spertus JA
Am Heart J; 2008 Dec; 156(6):1117-23. PubMed ID: 19033007
[TBL] [Abstract][Full Text] [Related]
10. Modification of Erythrocyte Membrane Fatty Acid Contents After Kidney Transplantation: A Prospective Study.
Son YK; Kwon H; Lee HW; Jeong EG; Lee SM; Kim SE; Park Y; An WS
Transplant Proc; 2018 Jun; 50(5):1332-1335. PubMed ID: 29880354
[TBL] [Abstract][Full Text] [Related]
11. Fatty acids linked to cardiovascular mortality are associated with risk factors.
Ebbesson SO; Voruganti VS; Higgins PB; Fabsitz RR; Ebbesson LO; Laston S; Harris WS; Kennish J; Umans BD; Wang H; Devereux RB; Okin PM; Weissman NJ; MacCluer JW; Umans JG; Howard BV
Int J Circumpolar Health; 2015; 74():28055. PubMed ID: 26274054
[TBL] [Abstract][Full Text] [Related]
12. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
13. Serum and adipose tissue fatty acid composition as biomarkers of habitual dietary fat intake in elderly men with chronic kidney disease.
Huang X; Sjögren P; Cederholm T; Ärnlöv J; Lindholm B; Risérus U; Carrero JJ
Nephrol Dial Transplant; 2014 Jan; 29(1):128-36. PubMed ID: 23229929
[TBL] [Abstract][Full Text] [Related]
14. Long chain fatty acids metabolism and cardiovascular risk factors in youth with type 1 diabetes.
Morandi A; Piona C; Bonafini S; Marigliano M; Tomasselli F; Tagetti A; Marcon D; Costantini S; Fava C; Maffeis C
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):297-305. PubMed ID: 33500106
[TBL] [Abstract][Full Text] [Related]
15. Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
Căpuşă C; Ştefan G; Stancu S; Lipan M; Tsur LD; Mircescu G
Medicine (Baltimore); 2017 Nov; 96(47):e8802. PubMed ID: 29381982
[TBL] [Abstract][Full Text] [Related]
16. Fatty Acid Profile of Mature Red Blood Cell Membranes and Dietary Intake as a New Approach to Characterize Children with Overweight and Obesity.
Jauregibeitia I; Portune K; Rica I; Tueros I; Velasco O; Grau G; Trebolazabala N; Castaño L; Larocca AV; Ferreri C; Arranz S
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33182783
[TBL] [Abstract][Full Text] [Related]
17. Variation in human erythrocyte membrane unsaturated Fatty acids: correlation with cardiovascular disease.
Sepulveda JL; Tanhehco YC; Frey M; Guo L; Cropcho LJ; Gibson KM; Blair HC
Arch Pathol Lab Med; 2010 Jan; 134(1):73-80. PubMed ID: 20073608
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Fatty Acid Profiles in a Group of Female Patients with Chronic Kidney Diseases (CKD) and Metabolic Syndrome (MetS)⁻Similar Trends of Changes, Different Pathophysiology.
Szczuko M; Kaczkan M; Drozd A; Maciejewska D; Palma J; Owczarzak A; Marczuk N; Rutkowski P; Małgorzewicz S
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959940
[TBL] [Abstract][Full Text] [Related]
19. Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.
Jacobs S; Schiller K; Jansen E; Fritsche A; Weikert C; di Giuseppe R; Boeing H; Schulze MB; Kröger J
Eur J Clin Nutr; 2014 Apr; 68(4):517-25. PubMed ID: 24569539
[TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin on erythrocyte membrane fatty acid contents in patients with chronic kidney disease.
Lee SM; Son YK; Kim SE; Kim YH; Park Y; An WS
Kidney Res Clin Pract; 2021 Sep; 40(3):392-400. PubMed ID: 34078022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
